Compounds > 6-methyl-2-ethyl-3-hydroxypyridine
Page last updated: 2024-09-02

6-methyl-2-ethyl-3-hydroxypyridine and Age-Related Macular Degeneration

6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Age-Related Macular Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konovalova, NV; Naritsyna, NI; Shpak, NI1

Other Studies

1 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Age-Related Macular Degeneration

ArticleYear
[Taufon and emoksipin in the combined treatment of sclerotic macular dystrophies].
    Oftalmologicheskii zhurnal, 1989, Issue:8

    Topics: Aged; Combined Modality Therapy; Drug Evaluation; Female; Follow-Up Studies; Humans; Macula Lutea; Macular Degeneration; Male; Middle Aged; Picolines; Sclerosis; Taurine; Time Factors; Visual Acuity

1989